295 followers
RT @FrontPharmacol: New Research: Disitamab vedotin in combination with immune checkpoint inhibitors for locally and locally advanced bladd…
RT @FrontPharmacol: New Research: Disitamab vedotin in combination with immune checkpoint inhibitors for locally and locally advanced bladd…
New Research: Disitamab vedotin in combination with immune checkpoint inhibitors for locally and locally advanced bladder urothelial carcinoma: a two-center’s real-world study #pharmacology https://t.co/GlTZdVpgnx